| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 May 24 | FNA Paragon 28 | Common Stock | Grant | Acquire A | No | No | 0 | 15,906 | 0.00 | 40,216 |
| 7 May 24 | BAX Baxter International | Common Stock, $1 par value | Grant | Acquire A | No | No | 0 | 5,952 | 0.00 | 27,901 |
| 11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.51 | 4,273 | 32.09 k | 0 |
| 11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.9984 | 683 | 3.41 k | 0 |
| 11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.6439 | 683 | 4.54 k | 0 |
